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Background: Bacterial vaginosis (BV), the most common vaginal condition of reproductive-aged women, is
associated with a highly diverse and heterogeneous microbiota. Here we present a proof-of-principle analysis to
uncover the function of the microbiota using meta-RNA-seq to uncover genes and pathways that potentially
differentiate healthy vaginal microbial communities from those in the dysbiotic state of bacterial vaginosis (BV).
Results: The predominant organism, Lactobacillus iners, was present in both conditions and showed a differing
expression profile in BV compared to healthy. Despite its minimal genome, L. iners differentially expressed over 10%
of its gene complement. Notably, in a BV environment L. iners increased expression of a cholesterol-dependent
cytolysin, and of mucin and glycerol transport and related metabolic enzymes. Genes belonging to a CRISPR system
were greatly upregulated suggesting that bacteriophage influence the community. Reflective of L. iners, the
bacterial community as a whole demonstrated a preference for glycogen and glycerol as carbon sources under BV
conditions. The predicted end-products of metabolism under BV conditions include an abundance of succinate and
other short-chain fatty-acids, while healthy conditions are predicted to largely contain lactic acid.
Conclusions: Our study underscores the importance of understanding the functional activity of the bacterial
community in addition to characterizing the population structure when investigating the human microbiome.
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Studies using high-throughput metagenomic and 16S
rRNA sequencing have identified over 250 bacterial
types in the human vagina. Microbial profiles in
women who are clinically healthy most often have a
low diversity microbiota dominated by lactobacilli with
the most common species being Lactobacillus crispatus,
Lactobacillus iners, Lactobacillus jensenii, and Lactobacillus
gasseri [1-4]. Conversely, for bacterial vaginosis (BV),
an aberrant condition associated with increased risk of
sexually transmitted infections and preterm labor [5,6],
several high-diversity, multi-species profiles have been
reported [3,7]. This makes the human vaginal microbiota* Correspondence: ggloor@uwo.ca
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reproduction in any medium, provided the ordifferent than other human microbial ecosystems where a
high species diversity correlates with healthy conditions.
For example and in contrast, inflammatory bowel disease
is characterized by a loss of diversity [8]. The vaginal
microbiota is highly dynamic and bacterial populations
can change rapidly between the healthy and BV states
[1,4,9], but the cause for these transitions is unknown.
The most frequently detected organism, Lactobacillus
iners, appears to have a streamlined genome adapted for
persistence in the vagina [10]. This organism is detected in
women regardless of BV status [7,11], but not much is
known about how L. iners can adapt to these differing envi-
ronments or its role in the etiology and pathogenesis of BV.
Although there are numerous 16S rRNA studies of the
vaginal microbiome that analyze the relative microbial
composition, for example, Ravel et al., Hummelen et al.,
and Lamont et al. [1,3,12], none have yet attempted toral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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culture-independent methods. We therefore chose a
meta-transcriptomic approach using RNA-seq to address
the functional contribution of the bacterial community. We
further sought to understand the function of Lactobacillus
iners, an organism found nearly ubiquitously in the vagina.
Results and discussion
Vaginal swabs from four women were collected for
RNA-seq of the bacterial transcriptome. Two women were
diagnosed with BV and two with a healthy (non-BV, N)
vaginal profile according to the low Nugent score, vaginal
pH, and signs and symptoms of the condition as noted by
the examining clinician (see Additional file 1: Table S1 for
Nugent scoring). Sequenced reads were mapped against a
reference coding sequence library (refseqs - see Methods)
resulting in 5,487,128 to 10,635,713 uniquely mapped
reads per sample, far exceeding the sequencing depth of
recent RNA-seq studies [13-15]. The number of unique
refseqs mapped ranged from 10,770 to 22,860 per sample,
with more refseqs expectantly identified in BV samples due
to the higher microbial diversity (mapping is summarized
in Additional file 1: Table S2). Among all four samples,
33,412 unique refseqs were identified in total. To verify the
completeness of our reference library and ensure no major
known taxon was missing from analysis, we performed an
independent mapping against a reference cpn60 gene
database. The highly expressed cpn60 (or groEL) gene is
nearly universally conserved in bacteria and contains a
variable sequence, which allows for taxonomic discrimin-
ation [16], and unlike the rRNA molecules, is not depleted
by the mRNA enrichment process. Mapped cpn60 reads
representing at least 0.1% of the total cpn60 mapped
reads are presented in Additional file 1: Table S3. The
data suggested that our reference library contained
representative genomes for the most abundant organisms
detected in our samples, and that any unavailable genomes
would not make up an appreciable fraction of the bacterial
or mRNA population.
The fraction of mapped reads per taxon for each sample
is represented in Figure 1A. The microbiota associated with
health, samples N4 and N30, were dominated by lactobacilli
(L. iners and L. crispatus), while those associated with BV,
B27 and B31, were a mixed population composed of lacto-
bacilli and anaerobic organisms that included Prevotella,
Gardnerella, and Megasphaera. The profiles are consistent
with those from healthy women and those with BV studied
by others [1-4], and corresponded to the Nugent profile for
each sample (Additional file 1: Table S1).
The multi-organism composition of our samples and the
resulting gene diversity violates assumptions of current
differential RNA-seq analysis methods. These methods
generally perform well when used to study the tran-
scriptome of single organisms, however they implicitlyassume that the expected between-condition difference
is essentially a fixed effect [17,18]. Since each sample
in this study was obtained from a different subject, a
random-effect type model is more appropriate. However, it
can be problematic to use this model when there are not
enough samples to accurately estimate the additional
parameter(s) required by random-effect models. We
therefore developed a specialized statistical framework
termed analysis of variance (ANOVA)-like differential
expression (ALDEx) (Fernandes et al., unpublished work)
that infers differential expression by estimating the
magnitude of between-condition expression difference
with respect to within-condition expression difference.
Thus genes (or functional groups) identified as differentially
expressed between the N and BV conditions have a
between-condition (N vs BV) expression difference that is
large in comparison to the within-condition (B27 + B31
and N4 + N30) variability. Furthermore, since we posit that
biochemical function, not organism is the major unit of
analysis for the vaginal microbiome, the data were grouped
via refseqs into functional groups (KO or SEED subsys4)
unless otherwise noted. Functional-level analyses of
metagenomic data, as opposed to gene-level analyses,
have been used previously [19]. Unsupervised hierarchical
clustering showed that samples were more similar when
refseqs were grouped by function (Additional file 1: Figure
S2B) than clustering by refseq expression (Additional file 1:
Figure S2A). We also noted, regardless of refseq grouping,
the two BV samples were most similar to each other based
on gene expression and were separable from the two N
samples that also clustered together. Estimated between-
vs within-expression ratios along with read counts and
annotations are presented in Additional file 2: Table S8
(iners refseqs), Additional file 3: Table S9 (subsys4) and
Additional file 4: Table S10 (KEGG KOs).
Response of L. iners to BV
L.iners is the most frequently detected vaginal organism,
and is known for its consistent presence in N and BV
states [1,3,20]. We detected L. iners in our samples
with an average coding sequence (CDS) coverage per
sample ranging from approximately 5-fold to 117-fold
(Additional file 1: Table S5). This allowed us to uncover
gene expression differences in this organism between the
two vaginal conditions.
We mapped a total of 1,653 unique L. iners CDS with
at least one read and refer to this set as the L. iners
pan-transcriptome (Figure 2). There were 954 of the
1,653 CDS present in all 12 L. iners genomes that represent
the core-expressed CDS set. The core functions, in general,
had a high relative expression and low fold-change between
conditions (Figure 2). A total of 207 CDS were inferred to
be differentially regulated due to their large estimated
between- vs -within expression ratios. These ratios, along
Figure 1 Bacterial community structure and function. (A) The distribution of all mapped mRNA reads for each taxon per sample. The two
samples that were considered healthy (N4 and N30) are dominated by Lactobacillus crispatus with lesser amounts of L. iners and L. jensenii
detected. The two samples having bacterial vaginosis (BV) have a lower relative proportion of lactobacilli and large proportions of Prevotella
amnii, Gardnerella vaginalis, Megasphaera, and other anaerobic organisms. (B) Selected subsystem 2 and subsystem 3 categories showing
enriched subsystem 4 functions under N or BV conditions. Each point represents a specific subsystem 4 function, and the magnitude of change
in expression is plotted on the x-axis relative to the BV condition. Points are colored blue (non-BV) or red (BV) if significantly differentially
expressed between conditions, whereas grey points are not differential between the conditions. (C) Representation of the fractional taxon
contribution to functions significantly upregulated in BV (red points in B). Pairs of bars represent the two samples (B27 and B31) and each color is
the fraction of reads for that function contributed by a particular taxon. Butyrate kinase, as part of the Acetyl-CoA fermentation to Butyrate
subsystem, is highlighted to show the relationship between the differential functions in 1B and the taxonomic composition of the function in 1C.
Gly, Glycerol; Gly-3P, Glycerol-3-phosphate; GL, Glycerolipid; GPL, Glycerophospholipid.
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Additional file 2: Table S8.
Amongst the most highly differentiated CDS were
eight contiguous genes encoding the proteins for the
CRISPR anti-bacteriophage defense system and include
the 5-member (CasA-CasE) protein complex, Cascade
(CRISPR-associated complex for antiviral defense) [21].
These CRISPR-related genes were highly expressed only
under BV conditions (Figure 1B, C, and Figure 2) suggesting
that L. iners is responding to an altered environmental
phage load. Interestingly, the cas proteins were only presentin 4/12 L. iners genomes (Figure 2) which raises the
question of strain-specific adaptations to the vaginal
environment that could not be identified by 16S rRNA
profiling. It is also possible that these differences
reflect different genome assembly qualities. We noted
that restriction-modification systems were also highly
upregulated by L. iners in BV (Additional file 1: Figure S3),
perhaps as further defense against bacteriophage infection.
The cas proteins, as part of the CRISPR anti-bacteriophage
system, regulate the insertion and presentation of small
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Figure 2 Circular representation of RNA-seq data for the Lactobacillus iners pan-transcriptome. RNA-seq reads were mapped to 12 available
L. iners genomes (listed in Additional file 1: Table S4) after clustering redundant coding sequences by nucleotide identity (see Methods). Breaks in the
circle separate blocks of contiguous coding sequences (CDS) ordered by scaffolding on the genome assemblies (Ring 1). The height of the plot
represents in how many of the 12 genomes the CDS occurs. The first contiguous block (dark blue) are the 954 CDS present in all genomes and are
considered the core L. iners gene set. Ring 2 shows the clusters of orthologous groups (COG) color-coded function of each CDS. Ring 3 The differential
expression of each CDS between non-bacterial vaginosis (BV) and BV samples. The absolute height of the bar shows the fold-change (log2) in
expression (positive for up BV, and negative for up non-BV). Bars are colored if significantly differential (red for BV and blue for non-BV). Regions of
interest are labeled in the centre of the circle. Rings 4, and 5, show a heatmap representation of the median CDS expression in BV and non-BV
samples, respectively. Darker blue represents higher expression. Regions of interest noted in the results are marked by lettered triangles.
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We therefore probed our RNA-seq data for evidence of
CRISPR spacer sequences and detected between 21,477
and 225,242 potential CRISPR spacers per sample of which
the vast majority corresponded to known sequences of
Lactobacillus origin (Additional file 1: Table S6). Examining
the meta-RNAseq data also revealed six highly upregulated
CRISPR-associated proteins (Figure 1B). Most of the reads
were contributed by L. iners (as described above), but there
was shared expression of these functions by G. vaginalis
and Megasphaera, and one of the cas proteins was
expressed only by Prevotella species (Figure 1C). Our
observations are supported by recent evidence that several
Lactobacillus-specific bacteriophage have been isolated
from women in South Africa with and without BV [23],and that metagenomic data from the Human Microbiome
Project has also revealed a diversity of CRISPRs in all body
sites, with an abundance of Lactobacillus-targeting phage
sequence in the vagina [24].
A notable core CDS, a cholesterol-dependent cytolysin
(CDC) encoded by L. iners [10], was upregulated at least
6-fold in BV (Figure 2B). This CDC is active between
pH 4.5 and 6.0 [25], which corresponds to the elevated
pH range of BV [26]. The predicted protein is similar to
vaginolysin, another CDC present in G. vaginalis that is
upregulated at least 256-fold in the meta-RNA-seq analysis
(Additional file 3: Table S9). Vaginolysin has been shown to
have cytotoxic activity towards human erythrocytes, vaginal
epithelial, and cervical cells [27]. This raises the possibility
that the L. iners-encoded CDC may play an unappreciated
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the condition.
Examination of the distribution of expressed reads
assigned to clusters of orthologous groups (COG) functions
showed an increase in transcriptional effort by L. iners for
carbohydrate transport and metabolism and a number
of individual CDS under this category were upregulated
in BV (Additional file 1: Figure S4). In the genomic context,
three separate loci involved in carbohydrate uptake
were upregulated 3- to 9-fold in BV (Figure 2: two loci
are marked in the region labeled A and the third in
the region labelled C). The first is a broad-specificity
phosphoenolpyruvate-dependent transport system (PTS) of
the mannose family along with a putative regulator of the
mannose operon, ManO, possibly targeting carbohydrate
moieties of the vaginal mucosa [10]. This PTS is conserved
in all 12 genomes of L. iners suggesting its functional
importance to the organism in the vagina. A second region,
also conserved across all sequenced L. iners genomes,
contains an ABC-type maltose transport system next to a
maltose phosphorylase suggesting a preference for maltose
uptake under BV. The source of maltose could be from
breakdown of glycogen by L. iners, and consistent with
this, there are four upregulated glycosylases predicted to
target α-1,6-glucocidic linkages that bridge the branching
points in glycogen. The third locus related to carbohydrate
utilization contains a second mannose-family PTS flanked
by an oligo-1,6-glucosidase de-branching enzyme and a
LacI family transcriptional regulator. This region is present
in only six of the twelve available L. iners genomes and
suggests that only a subset of strains are able to use
these genes for adaptation during BV.
Though glycogen is thought to be the major carbon
source for vaginal bacteria [28], we surprisingly noted
under BV conditions the upregulation of a tandem set of
three genes related to glycerol metabolism, including a
glycerol kinase, a glycerol-3-phosphate dehydrogenase, and
a glycerol facilitator (glpF) (region marked D in Figure 2).
The genes together suggest that L. iners is able to uptake
glycerol for conversion to glycerol-3-phosphate and
then glycerone phosphate for entry into glycolysis or
glycerophospholipid metabolism.
We examined the glycerol utilization genes in the
context of the meta-transcriptome (Figure 1B and C). The
glpF glycerol transporter and downstream glycerol kinase
are highly expressed by both L. iners and L. crispatus and
therefore results in no differential expression of these genes
at the community level. In addition to the glpF transporter,
L. iners and L. crispatus express a UGP-type glycerol-3P
transporter more strongly under N conditions. Prevotella
amnii, a BV-associated organism, also expressed an inde-
pendent glycerol-3P uptake system (glpT) (Additional file 3:
Table S9). By-passing the ATP-using phosphorylation of
glycerol by glycerol kinase, glpT and ugpB/E allows directuptake of glycerol-3-phosphate, which the organism can
use for phospholipid biosynthsis or conversion to
glycerone-P using glycerol-3-phosphate dehydrogenase
(expressed highly in BV) for entry into glycolysis. Two
enzymes (Glycerol-3-phosphate cytidylyltransferase
and Glycerol-3-phosphate O-acyltransferase) are expressed
highly under N conditions by L. iners and L. crispatus and
indicate glycerol-3P is also converted into products for
lipoteichoic acid and glycerophospholipid synthesis. The
overall high expression and the differential transcription of
these glycerol-related genes suggests glycerol is an underap-
preciated molecule in the vaginal bacterial ecosystem.
As an additional evaluation of gene expression by L. iners,
we collected and sequenced mRNA from a single L. iners
strain, AB-1, grown to mid-log phase in MRS broth (Difco,
BD Detroit, MI, USA). Additional file 1: Figure S10 and
Additional file 2: Table S8 summarize the mapping and
gene expression for this sample. Similar to the in vitro
expression data, core genes were highly expressed in vitro
and many potentially strain-specific genes were not
detected. Regions for carbohydrate uptake and metabolism
(marked A, C, and D in Figure 1 and in Additional file 1:
Figure S10) were amongst the most highly expressed.
One notable difference between the in vitro expression
compared to the clinical samples was the lack of CRISPR
expression (region E in Figure 1A and in Additional file 1:
Figure S10). Also notable, the cytolysin is highly expressed
under culture conditions. These data show that genes
that may be key for survival of L. iners in the vagina are
induced under in vitro conditions, opening possibilities
for future experiments to test gene expression and the
responding phenotype.
The vaginal community in BV
As described in Methods, we grouped refseqs (repre-
senting genes from one or multiple organisms) by their
annotated function in order to evaluate functional
differences between N and BV samples that may be
contributed by multiple organisms. Using SEED Sub-
system annotations, we estimated expression differ-
ences for subsys level 4 functions using ALDEx
(output is presented in Additional file 3: Table S9).
The expression of subsys4 level functions were visually
represented in two ways: 1) as strip plots where the subsys4
functions were plotted by absolute fold-change between
conditions (Figure 1B, and Additional file 1: Figure S5A,
B and C) colored by significance and 2) as heatmaps
where the summed expression value for each subsys4
was averaged over the number of genes per function
(Additional file 1: Figure S6A, B and C). The strip plot
allows us to visualize under which functional category
the subsys4 functions are binned, while the heatmaps
demonstrate the transcriptional effort by the community
for each function based on the subsys4 expression relative
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identifying differential functions, we can show the
taxonomic composition of the function (Figure 1C, and
Additional file 1: Figures S7 and S8, and in Additional file
5: Table S11, Additional file 6: Table S12, Additional file 7:
Table S13, Additional file 8: Table S14), allowing us to
discern which organisms are producing transcripts for
each function.
At the broadest functional level (SEED subsystem 1), the
most highly expressed subsys4 functions in both conditions
belong to general cell maintenance and information
processing functions such as cell division and cell
cycle, nucleosides and nucleotides, and RNA and DNA
metabolism (Additional file 1: Figure S6A). However,
many of the differentially expressed subsys4 functions
for these categories were more highly expressed under
the N condition (Additional file 1: Figure S5A). The
trend was conserved at the more specific SEED subsystems
level 2 and level 3 (Additional file 1: Figures S5B and C,
and S6B and C). This management of cell growth and
proliferation is consistent with known constraints on
apportioning cellular resources [29]. We suggest that
some of the transcriptional resources are necessarily
diverted from housekeeping tasks to other functions in
BV because of the greater diversity of organisms with a
wider array of metabolic capabilities.
Similar to the findings for L. iners, several functions
related to carbohydrate metabolism were found to differ
between N and BV samples at the SEED subsystem 2
and 3 levels (summarized in Figure 1B, and Additional
file 1: Figure S5B and C). The BV samples were enriched at
subsystem 2 functional categories of Glycoside hydrolases,
and Polysaccharides, and also at subsystem 3 in
Cellulosome, and Glycogen metabolism. The functions
belonging to these categories are enzymes involved in up-
take, degradation, and metabolism of glycans. Considering
the context of the vagina, these glycan-targeting genes
are likely used for the metabolism of glycogen, which
accumulates in the vaginal epithelium [30]. The genes
involved in these functions largely belong to P. amnii
and some to G. vaginalis (Additional file 9: Table S7). In
addition to several glycosidases and glycosyltransferases,
there are components of an outer membrane-bound
starch utilization system (Sus), belonging to P. amnii,
which are expressed in BV and have been implicated in
binding and transporting of starch by several intestinal
bacteria [31]. Interestingly, the upregulation of a starch
phosphorylase gene by P. amnii indicates it may be able
to synthesize glycogen via UDP-glucose; a phenomenon
observed in other Prevotella isolated from the ruminal gut
[32]. This could allow Prevotella to control carbohydrate
resources by storing excess for a time when it might be
needed due to growth needs, or limits in environmental
carbon sources. Supporting glycogen as an importantcarbon source for the BV organisms is the upregulation
of oligo-1,6-glucosidase and glucokinase, the enzymes
responsible for directing glycogen into glycolysis via
alpha-D-glucose.
Similar to the SEED subsystem analysis, we next grouped
the refseqs by Kyoto Encyclopedia of Genes and Genomes
(KEGG) KO numbers for differential expression analysis.
We used the KO and EC assignments to place differential
functions in corresponding KEGG pathways to examine
the community gene functions in the context of linked
metabolic pathways. Examined this way, the two conditions
differed primarily in energy metabolism. The major steps
of glycolysis and the conversion of pyruvate to lactic
acid was upregulated under N conditions, indicating
that lactic acid was the main metabolic end-product,
consistent with the predominance of lactobacilli in these
samples. In contrast, for the BV state, SEED subsystem
2 (Figure 1B, and Additional file 1: Figure S5B) showed
a number of upregulated functions in electron-donating
reactions belonging to steps of the tricarboxylic acid
(TCA) cycle and oxidative phosphorylation leading to
the production of succinate. A high ratio of succinate to
lactic acid was the original marker of BV [33,34], and
high succinate concentrations distinguish BV from the
similar but distinct condition of aerobic vaginitis (AV)
[35]. Increasing succinate at the expense of lactate results
in a self-perpetuating condition whereby an elevated pH
and a more reduced environment [36] supports the
growth of the anaerobic bacteria noted in BV. In addition
to succinate, we observed an upregulation of butyryl-CoA
dehydrogenase and butyrate kinase leading to butyrate
production from acetyl-CoA under BV conditions.
Examination of these functions linked to butyrate produc-
tion in SEED subsystems showed these were expressed
largely by P. amnii and by Megasphaera. Butyryl-CoA
dehydrogenase and butyrate kinase are shown as first and
second enzymes in the Acetyl-CoA to Butyrate function in
Figure 1C. These short-chain fatty acids have been shown
to modulate immune function in the vagina and these
anti-inflammatory properties may contribute to the non-
inflammatory nature of BV in contrast to the inflammatory
AV condition [35,37,38].
One of the distinctive characteristics of symptomatic
BV is the fishy odor upon application of 10% KOH
attributed to increased polyamines in the vaginal fluid
produced by amino acid breakdown [39]. P. amnii
expressed an arginine decarboxylase under BV conditions,
which could facilitate the synthesis of putrescine from
arginine. Interestingly, we also noted a spermidine synthase
gene expressed by Dialister and Megasphaera in BV, which
can convert putrescine to another polyamine, spermidine.
Although Dialister is a minor constituent of our samples, it
has been detected in vaginal studies and associated with
diverse microbiota profiles indicative of BV [1,7]. This
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process depending on the particular microbiota compos-
ition. Indeed, odor is not universally detected in women
who are BV-positive by Nugent score [40], and previous
studies suggest that particular taxa are more associated with
odor [3,41]. Symbiotic relationships may be common in the
vaginal environment, as another has been described where
G. vaginalis produces amino acids that promote the growth
of Prevotella bivia [42].
Conclusions
We used a novel method to characterize the conserved
differences between the meta-transcriptome of two healthy
and two BV microbial communities. Despite having four
distinct microbial populations, our results show that each
condition displays a set of conserved metabolic capabilities
that, while influenced by the organisms present, is largely
conserved between samples of differing structure. A
summary of major findings is presented in Figure 3. The
predicted metabolic end-products are known to produce
the acidic or strongly reduced environments associated

























Figure 3 Overview of predicted differential functions of the vaginal mic
present in the healthy condition results in a relatively simple environment wh
and inhibition of the growth of other anaerobic organisms. The more comple
in cell lysis, and an increase in carbohydrate availability. In this case, the carbo
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bacteriophage load, and the potential for several organisms to cooperate to phave an underappreciated role in this environment
with expression profiles suggesting upregulation of
pathways to use glycerol as a carbon source under BV
conditions. The source of glycerol is unknown, but it is
an abundant component of mammalian and bacterial
cell membranes, and extracellular glycerol levels are
used in clinical practice to measure loss of cellular integrity.
Thus, the rupture of cells by cytolysins expressed by L. iners
and G. vaginalis, as well as lipase activity could release
glycerol and glycerol components into the environment.
The BV-associated organism P. amnii showed enhanced
glycogen extraction during BV, as well as the ability to
synthesize its own glycogen. We posit a possible symbiotic
relationship between the BV-associated organisms in our
samples for the production of polyamines responsible for
vaginal odor during BV. We additionally found that the
vaginal microbiota respond to bacteriophage populations
differently in healthy and BV conditions. Several longitu-
dinal studies show rapid unexplained shifts in the vaginal
microbiota [4,9], and one study suggested that phage have a
role in the depletion of lactobacilli during episodes of BV
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populations may be markers of change in the bacterial
community [44].
We describe a different expression profile of L. iners in
health and BV. The persistence of L. iners under these
drastically differing environments (different pH, bacterial
population composition, and bacterial load) could be
due to its ability to respond and regulate its genomic
functions. We suggest some of these regulated functions,
such as specific carbohydrate uptake, bacteriophage
defense, and a cytolysin, could be adapted for survival
during episodes of BV. Some expressed functions were
attributed to a subset of the L. iners genomes. Strain-
specific functions of the microbiota, often overlooked by
current 16S rRNA sequencing studies, can be extracted
using function-based sequencing. Further investigation into
the role of L. iners as a passive or active participant in the
etiology and pathology of BV could help us understand this
highly prevalent condition.
Overall, examining the meta-vaginal transcriptome has
highlighted the complexity of this environment. The
large difference in bacterial function between the two
conditions emphasizes our need to better understand
the interactions between species in the context of the
rest of the community and of the host. It is likely that
examination of additional microbiota types associated
with health and BV will identify similar broad patterns,
but will provide additional insights into the association




Premenopausal women between the ages of 18 to 40
years were recruited at the Victoria Family Medical Center
in London, Canada. The Health Sciences Research Ethics
Board at the University of Western Ontario granted ethical
approval for the study. Participants were excluded from the
study if they had reached menopause, had a urogenital
infection other than BV in the past 6 months, were
pregnant, had a history of gonorrhoea, chlamydia,
estrogen-dependent neoplasia, abnormal renal function or
pyelonephritis, were taking prednisone, immunosuppresives
or antimicrobial medication, or had undiagnosed abnormal
vaginal bleeding. Participants were asked to refrain from
oral or vaginal intercourse and consuming probiotic
supplements or foods for 48 hours prior to the clinical visit.
No participants were menstruating at time of the clinical
visit. After reviewing details of the study, participants gave
their signed informed consent before the start of the study.
Vaginal swabs were collected from four women: two with
BV and two considered to have a non-BV vaginal micro-
biota (N) as diagnosed by Nugent scoring [45], and vaginal
pH (Additional file 1: Table S1). A nurse obtained vaginalsamples for RNA-seq using a Dacron polyester-tipped swab
rolled against the mid-vaginal wall and immediately
suspended in RNAprotect (Qiagen, Valencia, CA, USA)
containing 100 ug/ml rifampicin. A second swab col-
lected in the same way was smeared onto a slide and
air-dried for Nugent scoring [45] of bacterial vaginosis
(Nugent scoring is presented in Additional file 1: Table S1).
Vaginal pH was measured using the pHem-alert applicator
(Gynex, Redmond, WA, USA). Samples for RNA extraction
were incubated at room temperature for at least 10 minutes
(to a maximum of 3 hours), and then centrifuged before
discarding the supernatant and freezing the remaining
pellet at 80°C. Lysis and RNA extraction were performed
within 3 weeks of storage.
RNA isolation, mRNA enrichment, and sequencing
Cell pellets were lysed in a 700 ul solution of 20 mg/mL
lysozyme and 50 U/mL mutanolysin for 20 minutes at
37°C with periodic vortexing. After lysis, the samples were
centrifuged (5500 · g for 15 minutes) and the supernatant
was discarded. The remaining pellet was used for RNA
extraction by TRIzol (Invitrogen, Grand Island, NY, USA)
according to the manufacturer’s protocol. After RNA
isolation by TRIzol, 8 to 9 ug of total RNA was used for
rRNA depletion using a single round of MICROBExpress
(Ambion, Grand Island, NY, USA) according to the
manufacturer’s protocol. RNA quality and subsequent
rRNA depletion was verified before and after the
MICROBExpress treatment by the Agilent 2100 Bioanalyzer
(Bioanalyzer results before and after MICROBExpress
treatment shown in Additional file 1: Figure S1). Samples
were DNase-treated with the TURBO DNA-free kit
(Ambion, Grand Island, NY, USA). Samples were sent
to the Toronto Center for Applied Genomics (TCAG,
Toronto, Ontario, Canada) for library preparation and
sequencing by ABI SOLiD 4.
Reference sequence library and mapping
A total of 110 accessions representing 103 organisms
(of 31 genera, and 63 species) isolated from or detected
in the vagina were included in a reference sequence set
for mapping (Additional file 1: Table S4). The dataset
represents the partial or complete genomes available
from the NCBI database as of March 2011. These 234,991
sequences (including 230,031 coding sequences) were
clustered by sequence identity (95% nucleotide identity over
90% sequence length) using CD-HIT-EST [46] to remove
redundancy in the reference mapping set. A representative
sequence (refseq) from each of the resulting 163,014 clus-
ters was used to build a Bowtie [47] colorspace reference
library for mapping the RNA-seq reads. Reads mapped
uniquely by Bowtie to a coding refseq were included in the
differential expression analysis (all other unmapped reads
were discarded). Reads were trimmed from the 30 end
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Reads with equal best hits were mapped at random to
one of the locations.Functional assignment of refseqs
SOLiD colorspace format precludes direct functional
assignment of sequenced reads, and therefore, annotations
were assigned to the refseqs following mapping. Amino
acid translations of predicted coding sequences were
compared to the COG database [48] by rps-blast using an
e-value cutoff of 1e-3 to assign a COG function. SEED
Subsystems [49] were similarly assigned by blastp with an
e-value cutoff of 1e-3. The KEGG Automatic Annotation
Server (KAAS) [50] was used for annotation of enzyme
functions (KOs) and mapping of metabolic pathways. All
database comparisons and annotations were performed
on the data available as of April 2011.Statistical analyses for differential expression
We used the ALDEx R package version 1.3.0 (Fernandes et
al., unpublished work, http://code.google.com/p/aldex) for
differential expression analysis. Refseqs belonging to L. iners
were used to evaluate differential gene expression at
the single organism level. For differential expression of
the meta-bacterial community we modified the ALDEx
package to group refseqs into higher functional levels
(SEED subsystem4, and KEGG KO assignments). For
genes or functional groups to be considered differentially
expressed, we required a log2 relative difference (ΔR) of at
least 2.0 for function-level analysis and at least 1.5 for
L. iners gene-level analysis. To be considered differential
we also allowed less than 1% of the distributions between
the two conditions overlap. In the ALDEx output,
this is defined as the quantile of 0 and has the symbol
ΔAQ0 ≤ 0.01. A brief description of the statistical frame-
work is in the supplemental materials and is presented in
Additional file 1: Figure S9.CRISPR spacer analysis
CRISPR spacer sequences were downloaded from the
CRISPRs database (http://crispr.u-psud.fr/crispr/) and
RNA-seq reads were mapped to these sequences as
described for refseq mapping.cpn60 reference mapping
Sequences belonging to the cpn60 gene were downloaded
from cpnDB [16] and were manually curated to
remove redundant sequences (sequences with 100%
identity to another sequence in the database), so that
one representative sequence remained. RNA-seq reads
were mapped to this reference set as described for
refseq mapping.Additional files
Additional file 1: Supporting information (PDF). Contains Supporting
supporting text describing the statistical methodology, the supporting
figure and table headers and legends, Supporting Figures S1 to S10, and
Supporting supporting Tables S1 to S6.
Additional file 2: Table S8. Summary for Lactobacillus iners refseqs.
Additional file 3: Table S9. Analysis of variance-like differential
expression (ALDEx) ouptut for subsys4 functions.
Additional file 4: Table S10. Analysis of variance-like differential
expression (ALDEx) ALDEx output for KEGG KO functions.
Additional file 5: Table S11. Lookup for Figure S7A functions
(healthy, non-BV (N) condition).
Additional file 6: Table S12. Lookup for Figure S7B functions
(bacterial vaginosis (BV) condition).
Additional file 7: Table S13. Lookup for Figure S8A functions
(healthy, non-BV (N) condition).
Additional file 8: Table S14. Lookup for Figure S8B functions
(bacterial vaginosis (BV) condition).
Additional file 9: Table S7. Reads mapped to refseqs and annotations.
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